Longer-acting intravaginal formulation of buprenorphine
Ended Project Grant Awarded Last action
- Award ID
- R44DA053073
- Recipient
-
Auritec Pharmaceuticals, LLC UEI QX8KP6JKQ2L8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,490,450
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Funding
-
- $4,590,199.00 Federal
- $900,251.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $845,335 | $0 | |
| Amendment | $845,335 | $0 | |
| Amendment | $845,335 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $845,335 | $0 | |
| Amendment | $845,335 | $845,335 | |
| Amendment | $54,916 | $0 | |
| Amendment | $54,916 | $54,916 | |
| Original award | $253,692 | $0 |
Show all 14
Quick answers
Who received award R44DA053073?
R44DA053073 was awarded to Auritec Pharmaceuticals, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2020.
How much is award R44DA053073 worth?
$5,490,450 has been obligated on R44DA053073: $4,590,199 in federal funding and $900,251 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award